UK Markets closed

Global Microneedle Drug Delivery Systems Market Report 2021-2028 - Increasing Demand for a Safer Substitute to Conventional Hypodermic Injections

·5-min read

Dublin, Nov. 22, 2021 (GLOBE NEWSWIRE) -- The "Microneedle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Hollow, Dissolving, Solid, Coated), By Material (Metal, Silicon, Polymer), By Application, By Region, And Segment Forecasts, 2021-2028" report has been added to's offering.

The global microneedle drug delivery systems market size is expected to reach USD 8.10 billion by 2028

The market is expected to expand at a CAGR of 5.3% from 2021 to 2028. The growing demand for safer alternatives to the conventional hypodermic injection and increasing awareness regarding minimally invasive and pain-free administration of drugs are expected to boost the market growth.

Furthermore, the increasing cases of diabetes are expected to boost the market growth. For instance, according to the International Diabetes Federation (IDF), the number of diabetics has already reached 463 million and is predicted to rise in the next 10 years.

Drug delivery via microneedles is one of the most efficient procedures compared to traditional hypodermic injections. Microneedles are a self-administering platform for transdermal medication delivery that has a high drug bioavailability.

The microneedle design and drug formulation can control the dose, delivery rate, and efficacy of the medications. Microneedle also helps reduce or eliminate biohazardous sharps waste. In the coming years, microneedles are expected to have a greater impact on clinical care.

Microneedles are still under development and use a variety of drugs in clinical trials. The majority of studies have shown that this technique produces positive effects. This approach has the potential to be used for therapeutic purposes in a variety of fields.

For instance, Carnegie Mellon University is developing a COVID-19 vaccination injection method employing 3D printed hybrid microneedle arrays (Hybrid-MNA). The Hybrid-MNA approach not only allows for lower doses, but is also painless and has the potential to be self-administered.

These technologies are predicted to enable the production of microneedles at a cheaper cost. Microneedles have a wide range of applications, including vaccine administration, hormonal delivery, cancer therapy, pain management, and cosmetics.

Microneedle Drug Delivery Systems Market Report Highlights

  • The hollow type segment accounted for the largest revenue share in 2020 as they are considered ideal for the use of vaccine and hormonal therapy patients

  • The dissolving type segment is expected to grow at the fastest rate during the forecast period as it only requires one step and the microneedle needs not to be removed after insertion

  • The metal material segment accounted for the largest revenue share in 2020. Stainless steel and titanium are the most frequently employed metals

  • By application, the drug delivery segment dominated the market in 2020. The vaccine delivery segment is expected to register the fastest growth rate during the forecast period due to the increased awareness regarding vaccination among the population

  • Asia Pacific is anticipated to expand at the fastest CAGR over the forecast period due to the presence of untapped opportunities in the emerging economies, such as China and India

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis The increasing demand for a safer substitute to conventional hypodermic injections Increase in diabetic cases across the globe Technological advancements
3.4.2. Market restraint analysis Limited number of approved products Complications/risks associated with microneedles
3.5. Microneedle Drug Delivery Systems Market Analysis Tools
3.5.1. Industry Analysis - Porter's
3.5.2. PESTEL Analysis

Chapter 4. Microneedle Drug Delivery Systems: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Solid
4.1.2. Hollow
4.1.3. Dissolving
4.1.4. Coated
4.1.5. Others
4.2. Type Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Microneedle Drug Delivery Systems Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Solid
4.5.2. Hollow
4.5.3. Dissolving
4.5.4. Coated

Chapter 5. Microneedle Drug Delivery Systems: Material Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Silicon
5.1.2. Metal
5.1.3. Polymer
5.1.4. Others
5.2. Material Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Microneedle Drug Delivery Systems Market by Material Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Silicon
5.5.2. Metal
5.5.3. Polymer

Chapter 6. Microneedle Drug Delivery Systems: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Dermatology
6.1.2. Drug delivery
6.1.3. Pain management
6.1.4. Cancer therapy
6.1.5. Vaccine delivery
6.1.6. Others
6.2. Material Market Share, 2020 & 2028
6.3. Segment Dashboard
6.4. Global Microneedle Drug Delivery Systems Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.5.1. Dermatology
6.5.2. Hormone delivery
6.5.3. Pain management
6.5.4. Cancer therapy
6.5.5. Vaccine delivery

Chapter 7. Microneedle Drug Delivery Systems Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape

  • Raphas

  • Novartis International AG

  • Becton, Dickinson and Company

  • B. Braun

  • Nanopass Technologies Limited

  • Termo

  • Smiths Medical

  • Cardinal Health

  • 3M

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting